Vitamin D: How Much Is Enough, How Much Is Too Much

What vitamin D does in the body

Vitamin D is a fat soluble vitamin that behaves more like a hormone than a nutrient. The body makes it in skin when ultraviolet B light hits 7-dehydrocholesterol, and it can also be absorbed from food and supplements. Either route ends in the same place: the liver converts it to 25-hydroxyvitamin D, and the kidneys convert that into the active form, 1,25-dihydroxyvitamin D.

The job with the strongest evidence behind it is calcium and phosphate regulation. The active form increases calcium absorption in the gut and helps maintain serum calcium within a narrow range. Without enough vitamin D, calcium absorption drops, and the body pulls calcium from bone to keep blood levels steady.

Receptors for the active form turn up in many tissues, including immune cells, muscle, and pancreatic cells. That's the reason vitamin D has been studied against cancer, cardiovascular disease, diabetes, and multiple sclerosis. Presence of a receptor isn't evidence of benefit, and the trial record shows the difference clearly.

The official numbers, and what they assume

The Institute of Medicine published the current intake figures in 2010, and they have not been revised since. For adults 19 to 70 the Recommended Dietary Allowance is 600 IU per day. From age 71 it rises to 800 IU.

The assumption underneath matters. Those allowances were set for people getting minimal sun exposure, so they are meant to cover the winter months, indoor work, and high latitudes all at once. They were also set against one outcome only, bone health, because that was the one outcome with enough trial data to support a number.

The tolerable upper intake level for adults is 4,000 IU per day. The upper level applies to food and supplements together. It doesn't apply to sunlight, because the body limits how much it makes in skin.

The unit on US labels is IU, and the unit on many research papers is micrograms. One microgram of vitamin D equals 40 IU. A 400 IU capsule is 10 mcg, and a 5,000 IU capsule is 125 mcg. Reading both columns takes a second and prevents a tenfold mistake.

What a blood level actually tells you

The standard test measures 25-hydroxyvitamin D, usually written 25(OH)D. It reflects total exposure from sun, food, and supplements over the previous weeks.

The Institute of Medicine concluded that 20 ng/mL covers the bone health needs of 97.5% of the population. In the same review, the committee found that the bone benefit plateaus between 12 and 16 ng/mL. Someone sitting at 18 ng/mL isn't, by that reading, deficient.

Many clinicians aim higher, usually 30 ng/mL, based on observational work linking lower levels to falls and fractures. The disagreement is real, and it isn't resolved. A 2012 commentary in the Journal of Clinical Investigation put the practical problem plainly: a daily intake of 700 to 1,000 IU brought only about half of adults to 30 ng/mL, which means the official RDA leaves a substantial share of older adults below the level those clinicians want.

Two cautions on the test itself, because it's a moving target. Results vary between assays, and the same sample can read differently at two labs. Vitamin D status also moves with the season, so a level drawn in February isn't the level you carry in August.

What the largest trial found

The Vitamin D and Omega-3 Trial, known as VITAL, is the study to know about. It randomized 25,871 adults in the United States to 2,000 IU of vitamin D3 per day or placebo, with men 50 and older and women 55 and older, and followed them for a median of 5.3 years. Participants were not selected for low vitamin D, low bone mass, or osteoporosis. The trial was funded by the National Institutes of Health and other public funders, not by a supplement maker.

On cancer and heart disease, published in 2018: invasive cancer was diagnosed in 793 of 12,927 people taking vitamin D and 824 of 12,944 taking placebo, a hazard ratio of 0.96. Major cardiovascular events occurred in 396 and 409 people respectively, hazard ratio 0.97. Neither difference reached significance. Death from cancer came in at a hazard ratio of 0.83 with a confidence interval that crossed 1.0, which makes it a signal worth following, not a finding to act on.

On fractures, published in 2022: 1,991 fractures were confirmed across the trial. Total fractures came in at a hazard ratio of 0.98, nonvertebral fractures at 0.97, and hip fractures at 1.01. Supplementation did not lower fracture risk in this population.

The authors were careful about who the result applies to. People with vitamin D deficiency, low bone mass, or osteoporosis were not the study group, and the trial doesn't say anything about treating them. It also tested one dose, 2,000 IU per day. Higher doses were not compared.

Who ends up needing more than the RDA

The IOM identified groups whose intake needs attention, and the list has held up: older adults, people with dark skin pigmentation, people who live at high latitudes or stay indoors, and people with conditions that impair fat absorption.

Older skin makes less vitamin D from the same sun exposure, and older kidneys convert it less efficiently. Melanin reduces cutaneous synthesis, which is why the same sun exposure produces lower 25(OH)D in darker skin. Above roughly 37 degrees latitude, winter sunlight doesn't carry enough UVB for synthesis at all. Fat malabsorption from celiac disease, Crohn's disease, or bariatric surgery reduces absorption of a fat soluble vitamin and can call for doses well above the RDA.

Vitamin D also interacts with several drug classes. Orlistat and cholesterol lowering bile acid sequestrants reduce absorption. Anticonvulsants including phenytoin and phenobarbital accelerate the breakdown of 25(OH)D and the active form. Anyone on those medications has a reason to ask a clinician about monitoring rather than self dosing.

When a clinician prescribes a high dose

Clinical practice for confirmed deficiency looks nothing like the RDA. A common regimen is 50,000 IU once a week for six to eight weeks, followed by a maintenance dose in the 1,500 to 2,000 IU per day range, with a repeat blood test to confirm the level came up.

That regimen is a short course, and it's supervised. It exists because someone with a confirmed low level needs to come up quickly, and daily dosing at RDA levels can take months to get there. It isn't a reason to take 50,000 IU weekly for years.

Where too much starts

Vitamin D toxicity comes from hypercalcemia, which means calcium in the blood rises too high. The early signs are nausea, vomiting, weakness, and frequent urination. Sustained high calcium can damage the kidneys and calcify soft tissue.

Above the 4,000 IU upper level, the trial record splits in a way that's worth understanding. Timing matters as much as dose.

A trial published in the BMJ in 2003 gave 100,000 IU every four months to men and women aged 65 to 85 and found a reduction in fracture risk. A trial in the Journal of the American Medical Association in 2010 gave 500,000 IU once a year to older women and found more falls and more fractures in the treated group. An annual intramuscular dose of 300,000 IU of vitamin D2 was ineffective against nonvertebral fractures in a third trial.

The pattern suggests that large infrequent doses push 25(OH)D up sharply and then let it fall, and that the spike may increase bone resorption. Daily dosing avoids the spike. This is an argument for steady intake over heroic pulses, and it is also an argument against treating a low blood level with a single enormous dose outside supervision.

Above 10,000 IU per day for extended periods, cases of toxicity are documented. There is no established benefit above the upper level in the general population, and the VITAL results show that 2,000 IU per day already did not improve the outcomes tested.

D2 and D3 aren't the same on a label

Two forms appear in supplements. Vitamin D3, cholecalciferol, is the form made in human skin and the form used in VITAL. Vitamin D2, ergocalciferol, is made from yeast and is the form in most prescription 50,000 IU capsules.

A meta analysis published in the American Journal of Clinical Nutrition in 2012 pooled seven randomized trials and found that D3 raised 25(OH)D more than D2 at equivalent doses, and that D2 produced a faster decline when the dose stopped. A commentary the same year in the Journal of Clinical Investigation noted that the trials showing reductions in falls and fractures used both forms, with no consistent pattern of one beating the other on clinical outcomes.

Both statements can be true at once. D3 raises the blood marker more efficiently per unit, and the clinical trials have not shown that this translates into a difference in fractures or falls. The honest summary is that D3 is the more efficient way to raise the number, and the number isn't the same thing as the outcome.

Frequently asked questions

Do I need a blood test before taking vitamin D?

That's a clinical decision, not a reading decision. The trial evidence is clearest for people with known risk factors, and for them a baseline level makes the follow up interpretable. Without a baseline, there's no way to tell whether a supplement did anything.

Is 5,000 IU per day safe?

It's above the 4,000 IU tolerable upper intake level, which is set for the general population and includes food. Trials have run higher doses without detected harm in the short term, and the upper level isn't a toxicity threshold where problems begin at 4,001 IU. It's the point where the committee found the evidence base stopped being reassuring. Anyone taking 5,000 IU daily long term is outside the range the guidelines cover.

Does vitamin D help with mood or depression?

The trial record is mixed, and the largest studies have not shown a clear effect in people who were not deficient to begin with. VITAL tested depression as a secondary outcome and didn't change the picture.

Can I get enough from sun alone?

In summer at moderate latitude, brief exposure of arms and legs a few times a week is enough for most people. In winter above 37 degrees latitude, no amount of time outdoors will produce vitamin D in skin. Food helps but rarely closes the gap on its own, since few foods contain much vitamin D naturally.

Why does this page keep going back to one trial?

Because VITAL is the largest and longest randomized test of the question, and randomized trials carry more weight than observational work. When the largest trial disagrees with a dozen smaller ones, the largest trial usually wins, with the caveat that it tested one dose in one population.

---

This article is for general information only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Talk with your health care provider before starting any supplement, especially if you take medication or have a kidney condition.

Sources

• NIH Office of Dietary Supplements, Vitamin D Fact Sheet for Health Professionals
• Institute of Medicine, Dietary Reference Intakes for Calcium and Vitamin D, 2011 report summary, J Clin Endocrinol Metab
• Manson et al., Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease, NEJM 2018
• LeBoff et al., Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults, NEJM 2022
• Lyles, How much vitamin D should I take, J Clin Invest 2012
• Trivedi et al., Effects of four monthly 100,000 IU vitamin D3 on fractures and mortality, BMJ 2003
• Sanders et al., Annual high dose oral vitamin D and falls and fractures in older women, JAMA 2010